Journal
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume 47, Issue 6, Pages 666-684Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/CCLM.2009.159
Keywords
clinical proteomics; mass spectrometry; profiling; tumor
Categories
Ask authors/readers for more resources
Proteomics analysis has been heralded as a novel tool for identifying new and specific biomarkers that may improve diagnosis and monitoring of various disease states. Recent years have brought a number of proteomics profiling technologies. Although proteomics profiling has resulted in the detection of disease-associated differences and modification of proteins, current proteomics technologies display certain limitations that are hampering the introduction of these new technologies into clinical laboratory diagnostics and routine applications. In this review, we summarize current advances in mass spectrometry based biomarker discovery. The promises and challenges of this new technology are discussed with particular emphasis on diagnostic perspectives of mass-spectrometry based proteomics profiling for malignant diseases. Clin Chem Lab Med 2009;47:666-84.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available